Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-57.03	14.90	34.68
Graham Fair Price	41.42	16.96	11.99
PEG	-83.53	0.07	-0.40
Price/Book	-6.23	1.56	1.66
Price/Cash Flow	-51.02	27.60	56.35
Prices/Earnings	-53.12	6.50	13.87
Price/Sales	-53.12	1.77	3.78
Price/FCF	-51.02	27.60	56.35
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.11	0.09	0.09
Operating Margin	0.11	0.09	0.09
ROA	100.00	0.04	0.02
ROE	0.03	0.06	100.00
ROIC	0.02	0.06	137.17
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.10	-0.08	23.95
Dividends QOQ	2.21	< 0.005	-100.00
EBIT QOQ	-0.40	1.00	150.74
EPS QOQ	-0.34	0.98	184.68
FCF QOQ	-0.66	0.91	38.47
Revenue QOQ	-0.52	1.00	91.43
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	66.03	33.02	-49.99
Days Sales Outstanding (DSO)	31.01	16.14	-47.94
Inventory Turnover	1.36	2.73	99.98
Debt/Capitalization	0.24	0.08	-66.67
Quick Ratio	0.83	0.85	2.34
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	14.61	14.61	< 0.005
Cash	1.67	1.67	< 0.005
Capex	-0.34	-0.75	-116.06
Free Cash Flow	0.43	0.82	91.42
Revenue	6.42	12.84	100.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.79	1.79	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.63	1.88	-48.11
Naive Interpretation	Member

06 - Financial Health · Weak

Rating